Drug Markets/Orlistat

Orlistat

6 NDCs across 2 manufacturers|1 Generic,5 Brand

Orlistat is used to treat obesity, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Apr 23, 1999. In 2024, Medicare Part D spent $402K on Orlistat across 464 claims for 217 beneficiaries.

Orlistat is available as 6 NDCs from 2 manufacturers (1 generic, 5 brand), with NADAC prices from $0.45 to $7.00 per EAthe most expensive product costs about 15× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

6

1G / 5B

Manufacturers

2

competing in market

Price Spread

$0.45 – $7.00

per EA

7d Activity

114 flat

avg +0.3% WoW · of 6 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

2 manufacturers producing ORLISTAT

Drug Portfolio

6 NDCs total, 6 shown

Frequently Asked Questions

What is Orlistat used to treat?

Orlistat is used to treat obesity, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Orlistat?

In 2024, Medicare Part D spent $402K on Orlistat across 464 claims for 217 beneficiaries.

How many Orlistat products are on the market?

The Orlistat drug market contains 6 NDCs from 2 manufacturers — 1 generic and 5 brand products.

What is the price range for Orlistat?

NADAC reference prices for Orlistat range from $0.4536 to $7.0033 per EA — the most expensive product costs about 15× the cheapest.

Is generic Orlistat cheaper than brand?

The average generic NADAC for Orlistat is $7.0033 per EA, versus $1.2883 for brand-labeled products — brand is currently about 82% cheaper on average.

Which manufacturers make Orlistat?

2 manufacturers list Orlistat in NADAC. Ranked by number of NDCs, the largest are Haleon US Holdings LLC (4), H2-Pharma LLC (2).

How has the price of Orlistat changed recently?

Over the past 7 days, 1 Orlistat NDC rose and 1 fell, with a market-wide average change of +0.3%.